The maker's of a drug that treats age-related macular degeneration, a disease that can cause loss of sight, are taking the NHS to court to block them from using a drug that costs ten times less and is just as effective, according to tests.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
沒有留言:
張貼留言